6:30 am Alexion Pharma: FDA approves conversion of Soliris (eculizumab) accelerated approval in aHUS to regular approval for the treatment of patients with aHUS
View todays social media effects on ALXN
View the latest stocks trending across Twitter. Click to view dashboard
See who Alexion is hiring next, click here to view
